ASS1 and sarcoma: Thus, unlike other cancer cell lines deficient in ASS1 expression where treatment with ADI-PEG20 is lethal, exploitation of arginine auxotrophy by ADI-PEG20 in sarcoma cell lines results in cytostasis instead.